HU Group Holdings Inc (H.U.Group Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in the medical field for early detection and diagnosis. Its clinical laboratory testing services include collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back. H.U.Group Holdings provides various healthcare-related services, such as sterilization, clinical trial support and preventive medicine-related services. It offers sterilization services to hospitals in the Kanto, Chubu, Kansai, Chugoku and Kyushu regions. H.U.Group Holdings is headquartered in Tokyo, Japan.
Headquarters
Japan
Address
Akasaka Intercity Air, 1-8-1, Akasaka, Minato-Ku, Tokyo, 107-0052
Website
www.hugp.com
Telephone
81 3 62790801
No of Employees
5,437
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4544 (TYO)
Revenue (2022)
$1.9B
-4.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-47%
(2022 vs 2021)
Market Cap*
$886.8M
Net Profit Margin (2022)
XYZ
-44.6%
(2022 vs 2021)
* As of and is in US$
HU Group Holdings Inc premium industry data and analytics
Products and Services
| Services |
|---|
| Clinical Laboratory Testing Services |
| In Vitro Diagnostic Services |
| Healthcare Related Services |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In January, Fujirebio entered into an agreement with Agappe Diagnostics to provide the equipment for CLIA system reagents manufacturing project. |
| 2023 | New Products/Services | In December, Fujirebio Holdings Co. launched an automated chemiluminescent enzyme immunoassay system Mipulse G1200 and Lumipulse G600Ⅱ. |
| 2023 | Contracts/Agreements | In December, Fujirebio Holdings Co. and Sysmex Corporation entered into a business partnership agreement for the supply of reagent raw materials. |
Competitor Comparison
| Key Parameters | HU Group Holdings Inc | Alfresa Holdings Corp | Soiken Holdings Inc | Corin Japan KK | Toho Pharmaceutical Co., Ltd. |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Minato-Ku | Chiyoda-Ku | Toyonaka-Shi | Osaka | Setagaya ku |
| State/Province | Tokyo | Tokyo | Osaka | Osaka | Tokyo |
| No. of Employees | 5,437 | 11,772 | 98 | - | - |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Shigekazu Takeuchi | Chief Executive Officer; Director; President | Executive Board | 2020 | - |
| Naoki Kitamura | Director; Executive Officer | Executive Board | 2021 | - |
| Toshihiko Shimizu | Executive Officer | Senior Management | 2021 | - |
| Goki Ishikawa | Executive officer | Senior Management | 2020 | - |
| Kazuya Omi | Executive officer | Senior Management | 2019 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward